Lotus Pharm vs PEC: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ PEC

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYPECYoY
Oct 2026NT$2.13 billion-22.5%NT$2.84 billion+102.0%
Sep 2026NT$2.77 billion+128.0%NT$2.64 billion+100.0%
Aug 2026NT$2.11 billion+81.7%NT$2.62 billion+105.4%
Jul 2026NT$2.49 billion+3.9%NT$2.51 billion+92.6%
Jun 2026NT$3.4 billion+225.5%NT$2.33 billion+94.9%
May 2026NT$2.32 billion+105.8%NT$2.46 billion+108.5%
Apr 2026NT$3.09 billion+19.9%NT$2.06 billion+68.3%
Mar 2026NT$4.35 billion+173.6%NT$1.94 billion+64.4%
Feb 2026NT$2.24 billion+131.5%NT$1.6 billion+56.7%
Jan 2026NT$2.05 billion-5.5%NT$1.58 billion+49.8%
Dec 2025NT$2.44 billion+66.9%NT$1.92 billion+69.9%
Nov 2025NT$1.06 billion-0.2%NT$1.55 billion+53.0%
Oct 2025NT$2.75 billion+46.0%NT$1.4 billion+53.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16